What is the appropriate amoxicillin dosage for a 75‑lb (34‑kg) patient with streptococcal pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amoxicillin Dosage for 75 lb Patient with Strep Throat

For a 75 lb (34 kg) patient with streptococcal pharyngitis, prescribe amoxicillin 1000 mg once daily for 10 days, or alternatively 500 mg twice daily for 10 days. 1

Dosing Calculation and Rationale

The IDSA 2012 guidelines provide clear, evidence-based dosing for streptococcal pharyngitis with a strong, high-quality recommendation for amoxicillin 1:

  • Once-daily regimen: 50 mg/kg once daily (maximum 1000 mg)

    • For 34 kg: 50 × 34 = 1700 mg, but capped at 1000 mg once daily
  • Twice-daily regimen: 25 mg/kg (maximum 500 mg) twice daily

    • For 34 kg: 25 × 34 = 850 mg, but capped at 500 mg twice daily

Since this patient weighs less than 40 kg, they fall into the pediatric dosing category per FDA labeling 2. However, at 34 kg, they are close to the adult threshold and should receive the maximum pediatric dose, which equals the adult dose.

Treatment Duration

All patients must complete a full 10-day course to prevent acute rheumatic fever, regardless of symptom improvement 3, 1, 2. This is critical—even though patients typically become asymptomatic after a few days, the full course is necessary to eradicate Group A Streptococcus and prevent nonsuppurative complications 3.

Once-Daily vs. Multiple Daily Dosing

The once-daily regimen offers significant advantages:

  • Enhanced adherence: Simpler dosing improves compliance 3, 1
  • Equal efficacy: Multiple high-quality studies demonstrate once-daily amoxicillin is non-inferior to multiple daily dosing for bacteriologic cure 4, 5
  • Palatability: Amoxicillin suspension is more palatable than penicillin V 3

Research evidence supports this approach—a large controlled trial of 652 patients found once-daily amoxicillin was not inferior to twice-daily dosing, with failure rates of 2.8% vs 7.1% at final follow-up 4.

Administration Instructions

  • Take with food to minimize gastrointestinal intolerance 2
  • Patients become non-contagious after 24 hours of antibiotic therapy 3
  • If using suspension, shake well before each dose and refrigerate (though not required) 2

Common Pitfalls to Avoid

  1. Don't stop early: Even with rapid symptom improvement, the full 10-day course is mandatory to prevent rheumatic fever 3, 2
  2. Don't underdose: Using lower doses (e.g., 40 mg/kg/day) may result in higher treatment failure rates 6
  3. Don't use broad-spectrum alternatives unnecessarily: Penicillin and amoxicillin remain first-line due to narrow spectrum, proven efficacy, and lack of resistance 3, 1

Why Amoxicillin Over Penicillin V

While both are acceptable, amoxicillin is preferred because:

  • Once-daily dosing option improves adherence
  • Better palatability in suspension form
  • Comparable cost to penicillin V
  • No documented resistance by Group A Streptococcus 3, 1

The American Heart Association and IDSA both give amoxicillin their highest recommendation (strong, high-quality evidence) for treating streptococcal pharyngitis 3, 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.